Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Helix BioPharma (TSE:HBP)
TSX:HBP
Holding TSE:HBP?
Track your performance easily
HBP Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.50 - C$1.35
Previous CloseC$0.77
Volume7.84K
Average Volume (3M)10.86K
Market Cap
C$34.81M
Enterprise ValueC$36.67M
Total Cash (Recent Filing)C$1.08M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Dec 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding49,021,536
10 Day Avg. Volume29,105
30 Day Avg. Volume10,857
Standard Deviation0.21
R-Squared0.03
Alpha-0.00707
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Helix BioPharma News
PremiumCompany Announcements
Helix BioPharma Secures U.S. Patent for Cancer Therapy
PremiumCompany Announcements
Helix BioPharma to Acquire Laevoroc’s Oncology AssetsPremiumCompany Announcements
Helix BioPharma Unveils Promising Cancer Treatment
PremiumCompany Announcements
Helix BioPharma Highlights L-DOS47 at World ADC
PremiumCompany Announcements
Helix BioPharma Reports Fiscal Loss, Refocuses StrategyPremiumCompany Announcements
Helix BioPharma Announces New Transfer Agent
PremiumCompany Announcements
Helix BioPharma Expands Trading to Frankfurt BoersePremiumCompany Announcements
Helix BioPharma Announces Share Consolidation PlanOptions Prices
Currently, No data available
---
Ownership Overview
40.02%
Insiders
― Other Institutional Investors
59.98% Public Companies and
Individual Investors
HBP FAQ
What was Helix BioPharma’s price range in the past 12 months?
Helix BioPharma lowest stock price was C$0.50 and its highest was C$1.35 in the past 12 months.
What is Helix BioPharma’s market cap?
Currently, no data Available
When is Helix BioPharma’s upcoming earnings report date?
Helix BioPharma’s upcoming earnings report date is Dec 11, 2024 which is in 15 days.
How were Helix BioPharma’s earnings last quarter?
Helix BioPharma released its earnings results on Oct 24, 2024. The company reported -C$0.11 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.11.
Is Helix BioPharma overvalued?
According to Wall Street analysts Helix BioPharma’s price is currently Overvalued.
Does Helix BioPharma pay dividends?
Helix BioPharma does not currently pay dividends.
What is Helix BioPharma’s EPS estimate?
Helix BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Helix BioPharma have?
Helix BioPharma has 49,021,538 shares outstanding.
What happened to Helix BioPharma’s price movement after its last earnings report?
Helix BioPharma reported an EPS of -C$0.11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.67%.
Which hedge fund is a major shareholder of Helix BioPharma?
Currently, no hedge funds are holding shares in TSE:HBP
---
Helix BioPharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.04%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
44.70%
Trailing 12-Months
Company Description
Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
---
Technical Analysis
---